SBI Securities’s VanEck Biotech ETF BBH Stock Holding History

SBI Securities’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$73.6K	Sell	301 -4	-1%	-$893	﹤0.01%	1026
2026 Q2	$62K	Buy	305 +17	+6%	+$3.2K	﹤0.01%	1083
2026 Q1	$54.2K	Hold	288	–	–	﹤0.01%	1067
2025 Q4	$54.5K	Sell	288 -30	-9%	-$5.55K	﹤0.01%	1047
2025 Q3	$52.7K	Sell	318 -114	-26%	-$18.6K	﹤0.01%	1070
2025 Q2	$66.2K	Buy	432 +1	+0.2%	+$149	﹤0.01%	951
2025 Q1	$67.8K	Sell	431 -85	-16%	-$13.8K	﹤0.01%	871
2024 Q4	$81K	Buy	+516	New	+$86.8K	﹤0.01%	824

Other funds holding BBH

Paragon Private Wealth Management Lexington, Kentucky $326M AUM 26.55% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return

HFAS

Hummer Financial Advisory Services Chicago, Illinois $153M AUM 19.62% 1-Year Est. Return

Value Investment Professionals New York $115M AUM 13% 1-Year Est. Return

Cyndeo Wealth Partners St. Petersburg, Florida $2.21B AUM 17.29% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Plan A Wealth Lincoln, Nebraska $280M AUM 16.85% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Focus Financial Network Minneapolis, Minnesota $3.3B AUM 21.52% 1-Year Est. Return

BigSur Wealth Management Miami, Florida $423M AUM 18.98% 1-Year Est. Return

SBI Securities's BBH Position: Q3 2026 in Review

SBI Securities reduced its VanEck Biotech ETF (BBH) stake by 1.3% in Q3 2026, selling an estimated $893 and leaving 301 shares worth $73.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

SBI Securities first reported a position in BBH in Q4 2024 and has held it in 8 quarters since. The position peaked at $81K in Q4 2024. 18 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

SBI Securities held 301 shares of VanEck Biotech ETF worth $73.6K as of Q3 2026.
SBI Securities sold 4 VanEck Biotech ETF shares in Q3 2026, an estimated $893.
VanEck Biotech ETF made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #1026 holding.
SBI Securities first reported a position in VanEck Biotech ETF in Q4 2024 and has held it in 8 quarters since.
SBI Securities's VanEck Biotech ETF position peaked at $81K in Q4 2024.
18 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.